Current filters:  
UK
Food and Drugs Law
European Union
Reed Smith (Worldwide)
The Innovative Medicines Initiative (IMI) was created in 2008 as a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Arnold & Porter
The Neurim CJEU decision of July 2012 has arguably caused an equal amount of excitement and controversy.
Haseltine Lake Kempner LLP
The question as to whether an SPC can be obtained for a further use or new formulation of a previously approved drug has been the subject of much debate and speculation in recent years.
Herbert Smith Freehills
On 30 January 2020 the European Court of Justice ("ECJ") clarified for the first time the criteria governing whether so-called "pay-for-delay" agreements entered into between originator and generic
Herbert Smith Freehills
On 30 January 2020, the Court of Justice of the European Union (CJEU) issued its decision on a request for preliminary ruling ...
UK
Gowling WLG
In the UK, a recent decision of the Patents Court highlights the importance of ensuring that applicants for supplementary protection certificates ("SPCs") file the correct fee within the time permitted...
Shepherd and Wedderburn LLP
The UK Government's recent decision, in consultation with the devolved administrations, to close down all "non-essential premises" will have considerable impact on the licensed trade in Scotland.
Dentons
Following the death of a teenager after she suffered an allergic reaction to a baguette bought in a high street sandwich shop chain in 2016, new regulations will come into force in October...
Hogan Lovells
At the end of last week, the World Health Organisation (WHO) upgraded the global risk assessment of the novel coronavirus to "very high." This comes shortly after the United Kingdom ...
Haseltine Lake Kempner LLP
No expectation of solving the problem means no reason to modify the prior art, so no obviousness.
Mathys & Squire
The food and drink sector is the largest manufacturing sector in the UK — larger than the automotive and aerospace sectors combined.
Safecall
BRCGS issue 8 is an evolution from previous versions of the standard, but Issue 8 has introduced a number of significant changes.
Hogan Lovells
We are pleased to provide you with the third annual installment of our Life Sciences and Health Care Horizons guide.
Hogan Lovells
The U.S. Food and Drug Administration (FDA) today released significant changes to its recommendations for the use of laparoscopic power morcellators in gynecologic procedures
McCarthy Tétrault LLP
On February 13, 2020, the UK's Food Standards Agency (the "FSA") updated its business guidance on how it intends to regulate products for consumption containing cannabidiol ("CBD").
Arnold & Porter
The Food Standards Agency (FSA), which regulates foods and food businesses in England, Wales and Northern Ireland, yesterday issued its long awaited statement on CBD in foods.
BCL Solicitors LLP
BCL partner, Richard Reichman, discusses allergen labelling changes and the Food Standards Agency's consultation on new technical guidance.
DLA Piper
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.
Dehns
Bringing a new drug to the clinic is a tortuous and extremely expensive process fraught with commercial risk. It seems that Artificial Intelligence is beginning to challenge this reality.
Squire Patton Boggs LLP
t is estimated (perhaps conservatively) that 1 – 2% of the UK adult population and 5 – 8% of children in the UK have a food allergy (not including intolerances), and in addition, one in 100 people have coeliac disease.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media